MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B7450 SX 011Summary: p38α inhibitor -
A8374 AZD8330Target: MEKSummary: MEK 1/2 inhibitor -
B1406 SB5908851 CitationSummary: Potent B-Raf inhibitor -
B7215 EO 1428Summary: p38α and p38β2 inhibitor -
B9015 IQ 3Summary: Selective JNK3 inhibitor -
A8207 AZD6244 (Selumetinib)3 CitationSummary: MEK inhibitor -
B1405 GW50742 CitationSummary: C-Raf inhibitor,potent and selective -
B7140 JX 401Summary: p38α inhibitor -
B9011 BI 78D3Summary: Competitive JNK inhibitor -
A5803 BIX 02188Target: MEKSummary: MEK5 inhibitor,potent and selective
